Amrutanjan Healt Q1 FY27 Results (NSE: AMRUTANJAN)

· Analysis by Alpha Inflection

Signal: Margin pressure

The read

The quarter marks a sharp operating slowdown: revenue rose 9.5% YoY to ₹10,296.88 lakh, but EBITDA fell 21.8% to ₹10.06 Cr and margin contracted 390bps to 9.8%; the ₹202.75 lakh lease-rent exceptional charge made the PAT decline steeper at 47.4%, while the loss-making ₹3,635.77 lakh Women's Hygiene & Personal Care segment remains the main execution drag.

Amrutanjan Healt Q1 FY27 key financials
MetricValueYoYQoQ
Revenue₹102.97 Cr9.5%-31.2%
EBIT₹8.14 Cr-28.2%
Net profit₹4.37 Cr-47.4%
EPS₹1.51-47.4%
EBIT margin9.8%

P&L walk

Revenue increased to ₹10,296.88 lakh, +9.5% YoY but -31.2% QoQ; EBITDA fell 21.8% YoY to ₹10.06 Cr and margin contracted to 9.8%, while PAT declined 47.4% to ₹436.57 lakh after a ₹202.75 lakh exceptional lease-rent charge.

Segments

OTC Products remained the only material profitable segment at ₹987.44 lakh result, while Women's Hygiene & Personal Care generated ₹3,635.77 lakh revenue but a ₹287.61 lakh loss and Beverages posted a ₹125.98 lakh loss; the new women's-hygiene plant therefore has yet to translate into segment profitability.

Key positives

Key concerns

Earnings quality: includes other income and an exceptional item

View original filing

Research and educational content only. Not investment advice.